Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open Label Study of the Use of Magseed® Markers and Sentimag® to Localize Axillary Lymph Nodes With Biopsy-proven Metastases in Breast Cancer Patients

NCT03796559 is registered in ClinicalTrials.gov with Endomagnetics Ltd. as lead sponsor.

NCT NCT03796559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03796559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open Label Study of the Use of Magseed® Markers and Sentimag® to Localize Axillary Lymph Nodes With Biopsy-proven Metastases in Breast Cancer Patients
Lead sponsor
Endomagnetics Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
June 13, 2019
Completion date
May 31, 2027
Enrollment
65 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

axillary lymph nodes, breast cancer